Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for HAE

Stock NameHaemonetics Corporation
TickerHAE(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS4050241003
LEI549300ZEL6TXZS6F5F95

Show aggregate HAE holdings

News associated with HAE

Haemonetics Corporation (NYSE:HAE) Short Interest Up 41.9% in August
Haemonetics Corporation (NYSE:HAE – Get Free Report) was the recipient of a large growth in short interest during the month of August. As of August 15th, there was short interest totaling 4,370,000 shares, a growth of 41.9% from the July 31st total of 3,080,000 shares. Approximately 9.2% of the company’s stock are short sold. Based […] - 2025-09-10 04:58:58
Haemonetics (NYSE:HAE) Price Target Lowered to $70.00 at Mizuho
Haemonetics (NYSE:HAE – Free Report) had its target price reduced by Mizuho from $90.00 to $70.00 in a research report released on Friday,Benzinga reports. They currently have an outperform rating on the medical instruments supplier’s stock. A number of other equities analysts also recently commented on the stock. Raymond James Financial reiterated a “strong-buy” rating […] - 2025-08-11 02:56:42
Brokerages Set Haemonetics Corporation (NYSE:HAE) Target Price at $97.30
Shares of Haemonetics Corporation (NYSE:HAE – Get Free Report) have been assigned a consensus recommendation of “Buy” from the eleven analysts that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, eight have given a buy recommendation and two have assigned a strong buy recommendation […] - 2025-08-06 02:30:53
How The Pieces Add Up: SPMD Targets $63
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-28 08:27:27
Arizona State Retirement System Trims Position in Haemonetics Corporation (NYSE:HAE)
Arizona State Retirement System cut its holdings in shares of Haemonetics Corporation (NYSE:HAE – Free Report) by 3.0% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 14,407 shares of the medical instruments supplier’s stock after selling 446 shares during the quarter. Arizona State Retirement System’s holdings in Haemonetics were worth $916,000 at […] - 2025-07-21 06:12:11
Principal Financial Group Inc. Acquires 2,160 Shares of Haemonetics Corporation (NYSE:HAE)
Principal Financial Group Inc. lifted its stake in Haemonetics Corporation (NYSE:HAE – Free Report) by 1.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 158,894 shares of the medical instruments supplier’s stock after purchasing an additional 2,160 shares during […] - 2025-07-15 05:12:49
Haemonetics (NYSE:HAE) Raised to Buy at Citigroup
Haemonetics (NYSE:HAE – Get Free Report) was upgraded by stock analysts at Citigroup from a “neutral” rating to a “buy” rating in a research note issued to investors on Wednesday, MarketBeat.com reports. The brokerage presently has a $90.00 target price on the medical instruments supplier’s stock. Citigroup’s target price points to a potential upside of […] - 2025-07-11 02:20:48
Haemonetics Corporation (NYSE:HAE) Receives Average Rating of “Moderate Buy” from Brokerages
Shares of Haemonetics Corporation (NYSE:HAE – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eleven research firms that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation, seven have given a buy recommendation and two […] - 2025-07-09 04:53:34
KBC Group NV Grows Holdings in Haemonetics Corporation (NYSE:HAE)
KBC Group NV raised its position in Haemonetics Corporation (NYSE:HAE – Free Report) by 19.9% during the first quarter, Holdings Channel.com reports. The firm owned 2,417 shares of the medical instruments supplier’s stock after buying an additional 401 shares during the period. KBC Group NV’s holdings in Haemonetics were worth $154,000 at the end of […] - 2025-07-07 04:48:46
Vontobel Holding Ltd. Has $1.01 Million Holdings in Haemonetics Corporation (NYSE:HAE)
Vontobel Holding Ltd. increased its position in shares of Haemonetics Corporation (NYSE:HAE – Free Report) by 21.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,839 shares of the medical instruments supplier’s stock after acquiring an additional 2,828 shares during the period. Vontobel […] - 2025-07-06 06:01:06
Analysts Predict 15% Gains Ahead For IJJ
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-26 12:59:11
Haemonetics Co. (NYSE:HAE) Shares Bought by Rhumbline Advisers
Rhumbline Advisers increased its stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 1.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 161,123 shares of the medical instruments supplier’s stock after acquiring an additional 1,861 shares during […] - 2025-06-10 04:54:58
Two Sigma Investments LP Decreases Holdings in Haemonetics Co. (NYSE:HAE)
Two Sigma Investments LP trimmed its stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 24.1% during the 4th quarter, HoldingsChannel.com reports. The firm owned 58,799 shares of the medical instruments supplier’s stock after selling 18,675 shares during the quarter. Two Sigma Investments LP’s holdings in Haemonetics were worth $4,591,000 at the end […] - 2025-05-28 05:52:51
Nuveen Asset Management LLC Lowers Stock Holdings in Haemonetics Co. (NYSE:HAE)
Nuveen Asset Management LLC lowered its stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 11.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 161,452 shares of the medical instruments supplier’s stock after selling 19,887 shares during the quarter. […] - 2025-05-27 04:44:56
Analysts Set Haemonetics Co. (NYSE:HAE) PT at $97.89
Shares of Haemonetics Co. (NYSE:HAE – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the nine research firms that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation, six have issued a buy recommendation and […] - 2025-05-23 03:14:52
Nomura Holdings Inc. Invests $519,000 in Haemonetics Co. (NYSE:HAE)
Nomura Holdings Inc. purchased a new position in Haemonetics Co. (NYSE:HAE – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 6,652 shares of the medical instruments supplier’s stock, valued at approximately $519,000. A number of other hedge funds have also recently made changes […] - 2025-05-22 06:48:56
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 1,084 Shares of Haemonetics Co. (NYSE:HAE)
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 3.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 28,570 shares of the medical instruments supplier’s stock after purchasing an additional 1,084 shares during the […] - 2025-05-22 05:50:49
Captrust Financial Advisors Grows Position in Haemonetics Co. (NYSE:HAE)
Captrust Financial Advisors raised its position in Haemonetics Co. (NYSE:HAE – Free Report) by 14.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,872 shares of the medical instruments supplier’s stock after purchasing an additional 624 shares during the […] - 2025-05-20 04:50:49
Haemonetics (NYSE:HAE) Lowered to “Hold” Rating by StockNews.com
Haemonetics (NYSE:HAE – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Tuesday. HAE has been the topic of several other reports. Bank of America lowered Haemonetics from a “neutral” rating to an “underperform” rating and cut their target price […] - 2025-05-15 02:56:49
Schonfeld Strategic Advisors LLC Reduces Position in Haemonetics Co. (NYSE:HAE)
Schonfeld Strategic Advisors LLC lessened its stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 13.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 4,266 shares of the medical instruments supplier’s stock after selling 672 shares during the period. […] - 2025-05-13 05:38:48
Stifel Financial Corp Grows Position in Haemonetics Co. (NYSE:HAE)
Stifel Financial Corp lifted its position in Haemonetics Co. (NYSE:HAE – Free Report) by 7.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 14,776 shares of the medical instruments supplier’s stock after purchasing an additional 1,006 shares during the quarter. Stifel […] - 2025-05-09 05:26:56
Analysts Set Haemonetics Co. (NYSE:HAE) Price Target at $101.22
Haemonetics Co. (NYSE:HAE – Get Free Report) has received an average recommendation of “Moderate Buy” from the nine research firms that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation, six have given a buy recommendation and one has issued […] - 2025-04-28 02:39:01
Envestnet Asset Management Inc. Buys 4,217 Shares of Haemonetics Co. (NYSE:HAE)
Envestnet Asset Management Inc. boosted its stake in Haemonetics Co. (NYSE:HAE – Free Report) by 9.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 48,068 shares of the medical instruments supplier’s stock after purchasing an additional 4,217 shares during the […] - 2025-04-25 04:40:56
Bank of Montreal Can Sells 12,518,398 Shares of Haemonetics Co. (NYSE:HAE)
Bank of Montreal Can decreased its stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 99.9% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 7,933 shares of the medical instruments supplier’s stock after selling 12,518,398 shares during the quarter. Bank of Montreal Can’s holdings in Haemonetics were worth $619,000 as of […] - 2025-04-21 05:18:52
Federated Hermes Inc. Trims Holdings in Haemonetics Co. (NYSE:HAE)
Federated Hermes Inc. reduced its holdings in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 10.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 3,554 shares of the medical instruments supplier’s stock after selling 436 shares during the period. Federated Hermes Inc.’s holdings in Haemonetics […] - 2025-04-18 04:59:07
Haemonetics Co. (NYSE:HAE) Holdings Raised by Pictet Asset Management Holding SA
Pictet Asset Management Holding SA lifted its position in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 16.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,963 shares of the medical instruments supplier’s stock after acquiring an additional 979 […] - 2025-04-09 05:42:56
KLP Kapitalforvaltning AS Makes New Investment in Haemonetics Co. (NYSE:HAE)
KLP Kapitalforvaltning AS acquired a new stake in Haemonetics Co. (NYSE:HAE – Free Report) during the 4th quarter, Holdings Channel.com reports. The fund acquired 10,100 shares of the medical instruments supplier’s stock, valued at approximately $789,000. A number of other hedge funds also recently modified their holdings of HAE. Wellington Management Group LLP raised its […] - 2025-04-01 05:14:58
15,294 Shares in Haemonetics Co. (NYSE:HAE) Bought by Natixis Advisors LLC
Natixis Advisors LLC acquired a new stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund acquired 15,294 shares of the medical instruments supplier’s stock, valued at approximately $1,194,000. A number of other hedge funds have also recently modified their holdings of HAE. Parkside Financial Bank […] - 2025-03-26 05:54:45
Zurcher Kantonalbank Zurich Cantonalbank Acquires 1,202 Shares of Haemonetics Co. (NYSE:HAE)
Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Haemonetics Co. (NYSE:HAE – Free Report) by 10.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 12,460 shares of the medical instruments supplier’s stock after acquiring an additional 1,202 shares during the period. Zurcher […] - 2025-03-21 06:08:54
Needham & Company LLC Has Lowered Expectations for Haemonetics (NYSE:HAE) Stock Price
Haemonetics (NYSE:HAE – Get Free Report) had its target price cut by stock analysts at Needham & Company LLC from $108.00 to $104.00 in a report issued on Tuesday, Marketbeat reports. The brokerage currently has a “buy” rating on the medical instruments supplier’s stock. Needham & Company LLC’s target price indicates a potential upside of […] - 2025-03-20 04:28:54

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc HAE holdings

DateNumber of HAE Shares HeldBase Market Value of HAE SharesLocal Market Value of HAE SharesChange in HAE Shares HeldChange in HAE Base ValueCurrent Price per HAE Share HeldPrevious Price per HAE Share Held
2025-11-12 (Wednesday)35,698HAE holding decreased by -117USD 2,610,238HAE holding increased by 41228USD 2,610,238-117USD 41,228 USD 73.12 USD 71.73
2025-11-11 (Tuesday)35,815USD 2,569,010HAE holding increased by 44769USD 2,569,0100USD 44,769 USD 71.73 USD 70.48
2025-11-10 (Monday)35,815USD 2,524,241HAE holding increased by 75928USD 2,524,2410USD 75,928 USD 70.48 USD 68.36
2025-11-07 (Friday)35,815HAE holding decreased by -117USD 2,448,313HAE holding increased by 36916USD 2,448,313-117USD 36,916 USD 68.36 USD 67.11
2025-11-06 (Thursday)35,932USD 2,411,397HAE holding increased by 588926USD 2,411,3970USD 588,926 USD 67.11 USD 50.72
2025-11-05 (Wednesday)35,932HAE holding decreased by -1170USD 1,822,471HAE holding decreased by -46728USD 1,822,471-1,170USD -46,728 USD 50.72 USD 50.38
2025-11-04 (Tuesday)37,102HAE holding decreased by -234USD 1,869,199HAE holding decreased by -7682USD 1,869,199-234USD -7,682 USD 50.38 USD 50.27
2025-11-03 (Monday)37,336HAE holding decreased by -234USD 1,876,881HAE holding decreased by -1995USD 1,876,881-234USD -1,995 USD 50.27 USD 50.01
2025-10-31 (Friday)37,570USD 1,878,876HAE holding increased by 752USD 1,878,8760USD 752 USD 50.01 USD 49.99
2025-10-30 (Thursday)37,570USD 1,878,124HAE holding increased by 20663USD 1,878,1240USD 20,663 USD 49.99 USD 49.44
2025-10-29 (Wednesday)37,570USD 1,857,461HAE holding decreased by -34564USD 1,857,4610USD -34,564 USD 49.44 USD 50.36
2025-10-28 (Tuesday)37,570HAE holding increased by 351USD 1,892,025HAE holding decreased by -13960USD 1,892,025351USD -13,960 USD 50.36 USD 51.21
2025-10-27 (Monday)37,219USD 1,905,985HAE holding decreased by -1861USD 1,905,9850USD -1,861 USD 51.21 USD 51.26
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of HAE by Blackrock for IE00B3VWM098

Show aggregate share trades of HAE

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-12SELL-11774.17071.480 71.749USD -8,395 67.56 Loss of -490 on sale
2025-11-07SELL-11771.36067.310 67.715USD -7,923 67.52 Loss of -23 on sale
2025-11-05SELL-1,17051.72049.960 50.136USD -58,659 67.61 Profit of 20,440 on sale
2025-11-04SELL-23450.79050.000 50.079USD -11,718 67.70 Profit of 4,122 on sale
2025-11-03SELL-23450.32549.235 49.344USD -11,546 67.79 Profit of 4,316 on sale
2025-10-28BUY35150.36051.000 50.936USD 17,879 68.17
2025-10-24SELL-11751.26052.090 52.007USD -6,085 68.36 Profit of 1,913 on sale
2025-10-15BUY70248.58050.020 49.876USD 35,013 69.06
2025-10-02BUY11748.90048.920 48.918USD 5,723 69.28
2025-09-30BUY23448.74048.750 48.749USD 11,407 69.52
2025-08-21SELL-11753.98054.540 54.484USD -6,375 70.12 Profit of 1,829 on sale
2025-07-31BUY35174.04075.650 75.489USD 26,497 70.19
2025-07-28SELL-11774.66075.710 75.605USD -8,846 70.09 Loss of -645 on sale
2025-06-30SELL-23474.61075.050 75.006USD -17,551 69.49 Loss of -1,291 on sale
2025-06-25SELL-11773.40073.840 73.796USD -8,634 69.39 Loss of -515 on sale
2025-06-20SELL-23471.08071.470 71.431USD -16,715 69.34 Loss of -490 on sale
2025-05-30SELL-6,97667.71068.010 67.980USD -474,228 69.24 Profit of 8,770 on sale
2025-05-23BUY14166.06066.310 66.285USD 9,346 69.33
2025-05-19SELL-14169.36069.820 69.774USD -9,838 69.38 Loss of -56 on sale
2025-05-15SELL-42369.38069.460 69.452USD -29,378 69.37 Loss of -35 on sale
2025-05-12SELL-14270.23070.960 70.887USD -10,066 69.37 Loss of -215 on sale
2025-05-09SELL-14268.19069.530 69.396USD -9,854 69.38 Loss of -2 on sale
2025-04-30SELL-14263.02063.730 63.659USD -9,040 69.74 Profit of 864 on sale
2025-04-24SELL-28461.92062.030 62.019USD -17,613 70.03 Profit of 2,274 on sale
2025-04-22BUY1,43259.15059.310 59.294USD 84,909 70.24
2025-04-17SELL-13657.17058.460 58.331USD -7,933 70.66 Profit of 1,676 on sale
2025-04-15SELL-40858.30059.910 59.749USD -24,378 70.94 Profit of 4,566 on sale
2025-04-14SELL-40859.42060.770 60.635USD -24,739 71.07 Profit of 4,257 on sale
2025-04-09SELL-54461.03061.360 61.327USD -33,362 71.44 Profit of 5,502 on sale
2025-04-07SELL-95258.95063.070 62.658USD -59,650 71.77 Profit of 8,670 on sale
2025-04-04SELL-1,36060.88061.400 61.348USD -83,433 71.89 Profit of 14,342 on sale
2025-03-31BUY13663.55063.840 63.811USD 8,678 72.20
2025-03-19SELL-27265.23065.750 65.698USD -17,870 73.07 Profit of 2,006 on sale
2025-03-14SELL-81665.52067.030 66.879USD -54,573 73.41 Profit of 5,333 on sale
2025-03-13SELL-27265.93067.500 67.343USD -18,317 73.52 Profit of 1,680 on sale
2025-03-12SELL-4,62465.68068.380 68.110USD -314,941 73.63 Profit of 25,547 on sale
2025-03-07SELL-27268.70069.270 69.213USD -18,826 73.88 Profit of 1,270 on sale
2025-03-06SELL-41467.20068.350 68.235USD -28,249 73.99 Profit of 2,381 on sale
2025-03-03SELL-13865.08067.090 66.889USD -9,231 74.37 Profit of 1,032 on sale
2025-02-28SELL-2,72165.50066.620 66.508USD -180,968 74.51 Profit of 21,786 on sale
2025-02-26SELL-14264.93065.580 65.515USD -9,303 74.85 Profit of 1,325 on sale
2025-02-25SELL-42665.39066.180 66.101USD -28,159 75.01 Profit of 3,795 on sale
2025-02-18BUY71064.09064.230 64.216USD 45,593 76.04
2025-02-13BUY14262.29063.040 62.965USD 8,941 76.87
2025-02-12BUY14261.31062.480 62.363USD 8,856 77.18
2025-02-11BUY42661.54062.280 62.206USD 26,500 77.51
2025-02-06BUY1,27862.99065.960 65.663USD 83,917 78.61
2025-01-27BUY14271.29071.880 71.821USD 10,199 80.66
2024-12-30BUY71076.60077.470 77.383USD 54,942 81.38
2024-12-06BUY56881.19082.730 82.576USD 46,903 81.25
2024-12-05BUY14280.67083.220 82.965USD 11,781 81.27
2024-12-04BUY71083.51085.610 85.400USD 60,634 81.19
2024-11-29BUY71087.47088.860 88.721USD 62,992 80.53
2024-11-27BUY56887.89089.690 89.510USD 50,842 79.89
2024-11-26BUY14288.53089.600 89.493USD 12,708 79.49
2024-11-21BUY71085.43086.680 86.555USD 61,454 78.39
2024-11-20BUY42684.92085.330 85.289USD 36,333 78.03
2024-11-18BUY1,70488.17089.730 89.574USD 152,634 76.97
2024-11-12BUY1,13693.38094.990 94.829USD 107,726 75.87
2024-11-08BUY71087.42087.610 87.591USD 62,190 75.05
2024-11-07BUY2,11586.53087.500 87.403USD 184,857 74.17
2024-11-06BUY28278.16078.670 78.619USD 22,171 73.83
2024-10-31BUY14171.16072.250 72.141USD 10,172 74.36
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of HAE

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19354,1190830,76442.6%
2025-09-18165,1290510,26832.4%
2025-09-17210,1132,950595,72635.3%
2025-09-16228,0070504,66545.2%
2025-09-15191,132169535,24235.7%
2025-09-12296,0480699,58942.3%
2025-09-11137,1907,500413,25033.2%
2025-09-10160,6190261,60461.4%
2025-09-09124,2010216,08157.5%
2025-09-08140,35131261,72653.6%
2025-09-05104,14835220,00347.3%
2025-09-04170,7473336,87150.7%
2025-09-03134,7336,400316,35442.6%
2025-09-02126,5430268,59447.1%
2025-08-29110,28512,230336,54632.8%
2025-08-28119,3510251,76147.4%
2025-08-2782,5190166,91849.4%
2025-08-26149,3800247,21060.4%
2025-08-25162,4770272,53659.6%
2025-08-22195,123104363,80553.6%
2025-08-21148,9063,100285,78852.1%
2025-08-20202,3690435,12646.5%
2025-08-19160,6602,200437,04436.8%
2025-08-18132,76113270,68849.0%
2025-08-15219,1040386,11056.7%
2025-08-14225,7510587,56138.4%
2025-08-13206,5862,145441,05346.8%
2025-08-12227,869350547,61341.6%
2025-08-11232,1801,249509,66145.6%
2025-08-08285,3345,219793,66736.0%
2025-08-07774,84021,9642,347,23233.0%
2025-08-06225,5990338,29366.7%
2025-08-05149,3060376,32639.7%
2025-08-0481,2200148,17654.8%
2025-08-01111,1260180,25361.7%
2025-07-31133,7480236,45156.6%
2025-07-30121,0160160,32075.5%
2025-07-2987,84110145,55260.4%
2025-07-2868,9880101,94767.7%
2025-07-2567,2690108,36962.1%
2025-07-24120,9330199,01860.8%
2025-07-2370,5810139,28150.7%
2025-07-2299,3020181,52154.7%
2025-07-21122,5070250,68948.9%
2025-07-1896,8770360,83426.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.